Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STRN4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SIDT2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TMEM267 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PAGE5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ANKRD63 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MAN1A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | KCNA4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF426 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ACIN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |